Dna demethylase antisense and chemotherapy combination

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7088 (2006.01) A61K 31/04 (2006.01) A61K 31/713 (2006.01) A61K 38/14 (2006.01) A61K 45/06 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) C12N 15/11 (2006.01)

Patent

CA 2478124

The invention concerns a combination product comprising an antisense oligonucleotide of the gene encoding MBD2-demethylase and at least an agent used in antitumour chemotherapy, in particular bleomycin, for simultaneous, separate or prolonged use for treating proliferative and inflammatory diseases, in particular for cancer treatment.

La présente invention concerne un produit de combinaison comprenant un oligonucléotide antisens du gène codant pour la déméthylase MBD2 et au moins un agent utilisé en chimiothérapie antitumorale, en particulier la bléomycine, pour une utilisation simultanée, séparée ou étalée dans le temps pour le traitement des maladies prolifératives et inflammatoires, en particulier pour le traitement du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dna demethylase antisense and chemotherapy combination does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dna demethylase antisense and chemotherapy combination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dna demethylase antisense and chemotherapy combination will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2069684

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.